| Literature DB >> 34975746 |
Renata Finelli1, Sara Darbandi2,3, Peter Natesan Pushparaj4, Ralf Henkel1,5,6,7, Edmund Ko8, Ashok Agarwal1.
Abstract
Varicocele, a condition associated with increased oxidative stress, negatively affects sperm DNA integrity and reduces pregnancy rates. However, the molecular mechanisms related to DNA integrity, damage, and repair in varicocele patients remain unclear. This study aimed to determine the role of DNA repair molecular mechanisms in varicocele-related infertility by combining an in silico proteomics approach with wet-laboratory techniques. Proteomics results previously generated from varicocele patients (n=50) and fertile controls (n=10) attending our Andrology Center were reanalyzed using bioinformatics tools, including the WEB-based Gene SeT AnaLysis Toolkit, Open Target Platform, and Ingenuity Pathway Analysis (IPA), to identify differentially expressed proteins (DEPs) involved in DNA repair. Subsequently, selected DEPs in spermatozoa were validated using western blotting in varicocele (n = 13) and fertile control (n = 5) samples. We identified 99 DEPs mainly involved in male reproductive system disease (n=66) and male infertility (n=47). IPA analysis identified five proteins [fatty acid synthase (FASN), myeloperoxidase (MPO), mitochondrial aconitate hydratase (ACO2), nucleoporin 93 (NUP93), and 26S proteasome non-ATPase regulatory subunit 14 (PSMD14)] associated with DNA repair deficiency, which showed altered expression in varicocele (P <0.03). We validated ACO2 downregulation (fold change=0.37, change%=-62.7%, P=0.0001) and FASN overexpression (fold change = 4.04, change %= 303.7%, P = 0.014) in men with varicocele compared to controls. This study combined a unique in silico approach with an in vitro validation of the molecular mechanisms that may be responsible for varicocele-associated infertility. We identified ACO2 and FASN as possible proteins involved in DNA repair, whose altered expression may contribute to DNA damage in varicocele pathophysiology.Entities:
Keywords: DNA damage; DNA repair; male infertility; proteomics; varicocele
Mesh:
Substances:
Year: 2021 PMID: 34975746 PMCID: PMC8719329 DOI: 10.3389/fendo.2021.757592
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Bioinformatic analysis conducted by using (A) WEB-based Gene SeT AnaLysis Toolkit (WebGestalt), (B) Open Target Platform and (C) Ingenuity Pathway Analysis (IPA). KEGG, Kyoto Encyclopedia of Genes and Genomes.
Figure 2Differentially expressed proteins were categorized based on the functional annotation with GO terms in (A) biological processes, (B) cellular components, and (C) molecular functions.
List of differentially expressed proteins (DEPs) that are associated with male infertility, as reported by Open Targets Platform analysis.
| Disease full name | Relevance (p-value) |
| DEPs |
|---|---|---|---|
| Male reproductive system disease | 4.00E-22 | 66 | RSPH9, TTC25, PRKAR1A, FN1, PRKACA, IQGAP1, NDRG1, NDUFS1, CUL3, AK7, B2M, ACSL6, PDHA2, PSMD2, HIBADH, ATP1A4, H1-7, NME5, CCDC42, ODF2, CACNA2D2, RSPH6A, ITGB2, IDH3A, TEKT3, HSPA4L, HSPA2, CLGN, CS, ABHD10, IDH3B, ACADS, HADHA, FLNB, HMOX2, GAA, RUVBL1, DYNLL2, ACAT1, TGM4, SPA17, MPO, PSMD13, ACLY, EIF3F, HNRNPM, APOA1, DPCD, PSMD14, LETM1, PGAM5, TTR, EIF3I, KARS1, CPD, RAN, ACO2, CFAP58, AAAS, NUP93, IMMT, RABAC1, AZU1, CAPZA1, GFPT1, ITGAM |
| Male infertility | 8.00E-18 | 47 | RSPH9, TTC25, FN1, IQGAP1, NDUFS1, AK7, PDHA2, NME5, H1-7, CCDC42, ATP1A4, RSPH6A, CACNA2D2, ODF2, PRKACA, ITGB2, IDH3A, TEKT3, HSPA4L, HSPA2, CLGN, CS, ABHD10, IDH3B, PRKAR1A, NDRG1, ACADS, HADHA, FLNB, GAA, HMOX2, B2M, MPO, DPCD, APOA1, PGAM5, TTR, CUL3, KARS1, ACO2, RAN, CFAP58, AAAS, ACSL6, SPA17, TGM4, ACLY |
| Male infertility due to sperm motility disorder | 9.00E-13 | 23 | RSPH9, TTC25, AK7, CACNA2D2, NME5, ATP1A4, H1-7, RSPH6A, PRKACA, ODF2, TEKT3, CCDC42, PRKAR1A, HSPA4L, IDH3B, ABHD10, CLGN, HSPA2, DPCD, APOA1, MPO, ACO2, RAN |
| Male infertility due to sperm disorder | 5.00E-11 | 24 | RSPH9, TTC25, AK7, PDHA2, NME5, H1-7, ATP1A4, RSPH6A, CCDC42, CACNA2D2, PRKACA, ODF2, TEKT3, HSPA4L, PRKAR1A, ABHD10, HSPA2, IDH3B, CLGN, DPCD, APOA1, MPO, ACO2, RAN |
| Male infertility due to gonadal dysgenesis or sperm disorder | 3.00E-10 | 24 | RSPH9, TTC25, AK7, PDHA2, NME5, H1-7, ATP1A4, RSPH6A, CCDC42, CACNA2D2, PRKACA, ODF2, TEKT3, HSPA4L, PRKAR1A, ABHD10, HSPA2, CLGN, IDH3B, DPCD, APOA1, MPO, RAN, ACO2 |
| Male infertility due to obstructive azoospermia | 9.00E-09 | 19 | NDUFS1, AK7, CCDC42, ODF2, PRKACA, ATP1A4, NME5, ABHD10, RSPH6A, HSPA2, H1-7, CLGN, IDH3B, FN1, B2M, KARS1, PRKAR1A, MPO, APOA1 |
| Male infertility with teratozoospermia due to single gene mutation | 1.00E-08 | 14 | PRKACA, H1-7, ATP1A4, CCDC42, ODF2, AK7, RSPH6A, ABHD10, CLGN, HSPA2, IDH3B, TEKT3, HSPA4L, NME5 |
| Non-syndromic male infertility due to sperm motility disorder | 1.00E-08 | 11 | AK7, ATP1A4, H1-7, RSPH6A, CCDC42, ODF2, TEKT3, NME5, PRKACA, PRKAR1A, HSPA4L |
| Male infertility with spermatogenesis disorder due to single gene mutation | 5.00E-08 | 16 | AK7, PDHA2, CCDC42, H1-7, ATP1A4, PRKACA, NME5, ODF2, RSPH6A, HSPA4L, CLGN, ABHD10, IDH3B, HSPA2, TEKT3, PRKAR1A |
| Male infertility with spermatogenesis disorder | 5.00E-08 | 16 | AK7, PDHA2, CCDC42, H1-7, ATP1A4, PRKACA, NME5, ODF2, RSPH6A, HSPA4L, ABHD10, CLGN, HSPA2, IDH3B, TEKT3, PRKAR1A |
| Male infertility due to obstructive azoospermia of genetic origin | 7.00E-08 | 16 | NDUFS1, AK7, CCDC42, ATP1A4, PRKACA, ODF2, NME5, ABHD10, CLGN, RSPH6A, H1-7, IDH3B, HSPA2, FN1, B2M, PRKAR1A |
| Male infertility with azoospermia or oligozoospermia due to single gene mutation | 0.00005 | 10 | AK7, PDHA2, CCDC42, NME5, H1-7, ATP1A4, RSPH6A, HSPA4L, ODF2, TEKT3 |
Figure 3Western Blotting results in varicocele samples are expressed as percentage (%) change in comparison to fertile controls. This is calculated by analyzing 13 varicocele samples and 5 controls. (A) Graphic representation of the differential protein expression. *P<0.05. (B) Example of Western blotting results. FASN - fatty acid synthase (predicted molecular weight – pMW: 273kDa); MPO – myeloperoxidase (pMW: 83kDa); PSMD14 - 26S proteasome non-ATPase regulatory subunit 14 (pMW: 34.6 kDa); ACO2 - mitochondrial aconitate hydratase (pMW: 85.4 kDa); NUP93 - nucleoporin 93 (pMW: 93.5 kDa).
Figure 4Proposed mechanism explaining the association between differential proteins expression (aconitase 2 and FASN) and DNA damage and repair in varicocele condition.